The board of directors of Sinopharm Group Co. Ltd. announced that Dr. Liu Wei ("Dr. Liu") ceased to be the joint company secretary of the Company with effect from 27 April 2021 due to his retirement. The Board also announces that Mr. Chan Sing Yuen, Roy ("Mr. Chan") has been appointed as the new joint company secretary of the Company from 27 April 2021. Accordingly, the current joint company secretaries of the Company are Mr. Wu Yijian ("Mr. Wu") and Mr. Chan. The Board further announces that Mr. Chan has also been appointed as the agent of the Company for accepting service of process and notices on behalf of the Company in Hong Kong under Rule 19A.13(2) of the Listing Rules with effect from 27 April 2021. The Board would like to take this opportunity to express its gratitude to Dr. Liu for his contribution during his tenure as the joint company secretary and its warm welcome to Mr. Chan of his new appointment. Mr. Chan Sing Yuen, Roy, aged 55, graduated from the University of Leeds School of Law and the Chinese University of Hong Kong with a bachelor degree of law and a bachelor degree in social science, respectively. Mr. Chan is a practicing solicitor of the High Court of Hong Kong and a practicing solicitor of the Senior Courts of England and Wales. He has extensive experience in the financing and governance of listed companies and is a senior partner of DLA Piper. He is also an arbitrator of the Chinese European Arbitration Centre and the Shanghai International Arbitration Centre.